NCT00348361View on ClinicalTrials.gov

Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2005

Conditions
Allergic Rhinitis
Interventions
DRUG

Fluticasone Propionate

Trial Locations (2)

1105 AZ

GSK Investigational Site, Amsterdam

WC1X 8DA

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY